These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11479199)

  • 1. Expression profiling reveals hepsin overexpression in prostate cancer.
    Magee JA; Araki T; Patil S; Ehrig T; True L; Humphrey PA; Catalona WJ; Watson MA; Milbrandt J
    Cancer Res; 2001 Aug; 61(15):5692-6. PubMed ID: 11479199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
    Chen Z; Fan Z; McNeal JE; Nolley R; Caldwell MC; Mahadevappa M; Zhang Z; Warrington JA; Stamey TA
    J Urol; 2003 Apr; 169(4):1316-9. PubMed ID: 12629351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
    Luo J; Duggan DJ; Chen Y; Sauvageot J; Ewing CM; Bittner ML; Trent JM; Isaacs WB
    Cancer Res; 2001 Jun; 61(12):4683-8. PubMed ID: 11406537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer.
    Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Kishi T; Nakamura T; Loening SA; Diamandis EP
    J Urol; 2004 Jan; 171(1):187-91. PubMed ID: 14665873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.
    Halvorsen OJ; Oyan AM; Bø TH; Olsen S; Rostad K; Haukaas SA; Bakke AM; Marzolf B; Dimitrov K; Stordrange L; Lin B; Jonassen I; Hood L; Akslen LA; Kalland KH
    Int J Oncol; 2005 Feb; 26(2):329-36. PubMed ID: 15645116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
    Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
    Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
    Xuan JA; Schneider D; Toy P; Lin R; Newton A; Zhu Y; Finster S; Vogel D; Mintzer B; Dinter H; Light D; Parry R; Polokoff M; Whitlow M; Wu Q; Parry G
    Cancer Res; 2006 Apr; 66(7):3611-9. PubMed ID: 16585186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HEPSIN inhibits cell growth/invasion in prostate cancer cells.
    Srikantan V; Valladares M; Rhim JS; Moul JW; Srivastava S
    Cancer Res; 2002 Dec; 62(23):6812-6. PubMed ID: 12460890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of prognostic biomarkers in prostate cancer.
    Dhanasekaran SM; Barrette TR; Ghosh D; Shah R; Varambally S; Kurachi K; Pienta KJ; Rubin MA; Chinnaiyan AM
    Nature; 2001 Aug; 412(6849):822-6. PubMed ID: 11518967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.
    Welsh JB; Sapinoso LM; Su AI; Kern SG; Wang-Rodriguez J; Moskaluk CA; Frierson HF; Hampton GM
    Cancer Res; 2001 Aug; 61(16):5974-8. PubMed ID: 11507037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis.
    Li W; Wang BE; Moran P; Lipari T; Ganesan R; Corpuz R; Ludlam MJ; Gogineni A; Koeppen H; Bunting S; Gao WQ; Kirchhofer D
    Cancer Res; 2009 Nov; 69(21):8395-402. PubMed ID: 19843851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia.
    Stamey TA; Warrington JA; Caldwell MC; Chen Z; Fan Z; Mahadevappa M; McNeal JE; Nolley R; Zhang Z
    J Urol; 2001 Dec; 166(6):2171-7. PubMed ID: 11696729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
    Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
    Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiling in prostate cancer.
    Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
    Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma.
    Lucas JM; True L; Hawley S; Matsumura M; Morrissey C; Vessella R; Nelson PS
    J Pathol; 2008 Jun; 215(2):118-25. PubMed ID: 18338334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
    Ding Y; Xu L; Chen S; Jovanovic BD; Helenowski IB; Kelly DL; Catalona WJ; Yang XJ; Pins M; Ananthanarayanan V; Bergan RC
    Prostate Cancer Prostatic Dis; 2006; 9(4):379-91. PubMed ID: 16786039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gene expression profiling in prostatic cancer].
    Ernst T; Hergenhahn M; Kenzelmann M; Cohen CD; Ikinger U; Kretzler M; Hollstein M; Gröne HJ
    Verh Dtsch Ges Pathol; 2002; 86():165-75. PubMed ID: 12647366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
    Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
    Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepsin immunohistochemical expression in prostate cancer in relation to Gleason's grade and serum prostate specific antigen.
    Goel MM; Agrawal D; Natu SM; Goel A
    Indian J Pathol Microbiol; 2011; 54(3):476-81. PubMed ID: 21934206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.